Clinical trial for Fallopian Tube Patency Tests
Official title Assessment of Tubal Occlusion During Minimally Invasive Myomectomy
ClinicalTrials.gov ID: NCT06988774
What this study is testing
- What it's testing
- The study aims to learn how uterine fibroids and their surgical removal affect whether fallopian tubes are open or blocked.
- Who it's for
- Women who are scheduled for laparoscopic myomectomy to treat uterine fibroids.
- What's involved
- During the planned surgery, doctors will inject a small amount of blue dye into the uterus to see if it spills from the fallopian tubes, doing this test at the start and end of the operation. The results and fibroid details will be recorded.
- Time commitment
- The extra testing takes less than 10 minutes and is done during the same surgery, with no additional visits required.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Patients undergoing minimally invasive laparoscopic or robotic-assisted uterine-preserving gynecologic surgery for removal of uterine fibroids...
You likely can't join if
- Patients with both fallopian tubes absent
- Patients in whom it is not possible to place a uterine manipulator or catheter
- Patient with known tubal disease or occlusion, or patients who have undergone prior tubal surgery
- Patients with allergy to methylene blue dye or G6PD deficiency
- Patients with positive pregnancy test on day of surgery
The study team makes the final eligibility decision.
Where it is enrolling
- Washington D.C., District of Columbia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Washington D.C., District of Columbia, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.